The leading source for credible citizen reporting

News Stories Related To: Illumina DNA sequencing available, if not affordable, to the consumer

Boston : MA : USA | 5 months ago

The San Diego biotechnology company Illumina is launching a futuristic service that will give consumers the chance to get their DNA sequenced...The company, which specializes...

Share:
Read full report

Reach Credibility Credibility of 5

Related Allvoices Contributions

By: AnneHart

Report: Landmark study breakthrough in breast cancer DNA

about 1 month ago
By: DrMoskowitz

Report: Cancer research: an endless war?

17 days ago
By: BiodunIginla

Report: Governor signs bills that boost solar power

about 1 month ago

Related news stories

Add A News Story |
Filter By:
All All
| Local Local

MIT Technology Review: Hospital to Collect Patients' Genomic Data

News Source: Uinta County News | 5 months ago

Boston's Brigham and Women's Hospital (BWH) has announced plans to collect blood samples for genetic analysis from all consenting patients and then feed that information into a large database, allowing scientists to analyze patients' genomes...
MIT Technology Review: The Human Genome: Yours for $48,000

News Source: Androscoggin News | 5 months ago

The cost of a personal genome has dropped from about the price of a luxury sedan to, well, the price of a slightly less luxurious nice car. Illumina, a genomics technology company headquartered in San Diego, announced the launch of a $48,000 genome-...
Illumina DNA sequencing available, if not affordable, to the consumer

News Source: San Diego Union-Tribune | 5 months ago

The San Diego biotechnology company Illumina is launching a futuristic service that will give consumers the chance to get their DNA sequenced...The company, which specializes in DNA research tools for scientists, thinks consumer gene sequencing could...
Bio-IT World: Illumina To Offer $48,000 Personal Genome Sequencing Service

News Source: Androscoggin News | 5 months ago

Knome (via the Beijing Genomics Institute Shenzen) on the whole-genome sequencing front. But Flatley has wanted to move into personal genomics for several years. “It started right when we bought Solexa,” he told Bio-IT World . “We knew this is...